TNGX TANGO THERAPEUTICS INC

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference

BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 9:45am PST/12:45pm EST.

The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit

Investors and Media:

Elizabeth Hickin





EN
17/12/2025

Underlying

TNGXTANGO THERAPEUTICS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TANGO THERAPEUTICS INC

 PRESS RELEASE
Free
TNGX TANGO THERAPEUT...

Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, ...

Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor Founding CEO Barbara Weber, M.D. to become executive chair of the board of directorsMalte Peters, M.D., current board member, appointed President and Chief Executive Officer, effective immediately – BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines today announced the retirement of its Chief Executive Officer, Dr. Barbara Weber...

11h / 43m 1 EN
 PRESS RELEASE
Free
TNGX TANGO THERAPEUT...

Tango Therapeutics Appoints Sung Lee to Board of Directors

Tango Therapeutics Appoints Sung Lee to Board of Directors BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced the appointment of Mr. Sung Lee to the Board of Directors. Mr. Lee has over 20 years of experience in finance leadership in the biopharmaceutical and technology industries. "We are delighted to welcome Sung Lee to our Board of Directors," said Barbara Weber, M.D., Chief Executive Officer of Tango Therapeu...

January 5, 2026 1 EN
 PRESS RELEASE
Free
TNGX TANGO THERAPEUT...

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcar...

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 9:45am PST/12:45pm EST. The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the w...

December 17, 2025 1 EN
 PRESS RELEASE
Free
TNGX TANGO THERAPEUT...

Tango Therapeutics to Participate in the Piper Sandler 37th Annual Hea...

Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference BOSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Adam Crystal, M.D., Ph.D., President of Research & Development at Tango Therapeutics, is scheduled to participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3 at 1:30pm ET. The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast wi...

November 26, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 42.81
VCYT VERACYTE INC
MTH Meritage Homes ... ... (+14)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

VCYT VERACYTE INC
MTH MERITAGE HOMES CORPORATION
DHI D.R. HORTON INC.
COLM COLUMBIA SPORTSWEAR COMPANY
VFC V.F. CORPORATION
HBB HAMILTON BEACH BRANDS HOLDING COMPANY
TNDM TANDEM DIABETES CARE
QTRX QUANTERIX CORPORATION
WGO WINNEBAGO INDUSTRIES INC.
NRIX NURIX THERAPEUTICS
TNGX TANGO THERAPEUTICS INC
FTREV FORTREA HOLDINGS INC.
BBNX BETA BIONICS
SION SIONNA THERAPEUTICS INC
11/24/25 November 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch